Future studies may integrate GFAP scoring with detailed gene-level analyses to better understand how specific genes within the 4p16.3 region—such as NSD2 (associated with developmental delay), LETM1 (epilepsy), or CPLX1 (synaptic function)—modulate individual trajectories. The gene discussed is GFAP; the disease is Global developmental delay.